z-logo
open-access-imgOpen Access
mi RNA expression profiling of Epstein–Barr virus‐associated NKTL cell lines by Illumina deep sequencing
Author(s) -
Alles Julia,
Menegatti Jennifer,
Motsch Natalie,
Hart Martin,
Eichner Norbert,
Reinhardt Richard,
Meister Gunter,
Grässer Friedrich A.
Publication year - 2016
Publication title -
febs open bio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.718
H-Index - 31
ISSN - 2211-5463
DOI - 10.1002/2211-5463.12027
Subject(s) - rna , biology , microbiology and biotechnology , epstein–barr virus , gene expression , virus , non coding rna , cell culture , gene , gene expression profiling , virology , cancer research , genetics
The aim of this work was to establish the micro RNA profile of SNK 6 and SNT 16, two Epstein–Barr virus ( EBV )‐infected cell lines derived from nasal NK /T‐cell lymphoma ( NKTL ). The oncogenic EBV is strongly associated with the pathogenesis of nasal and extranodal NK /T‐cell lymphoma and expresses 44 mature micro RNA s and two noncoding EBV ‐encoded RNA s ( EBER s). mi RNA s are 19‐25nt noncoding RNA s that affect host and viral gene expression post‐transcriptionally. Deregulated mi RNA patterns are frequently linked to a variety of human cancers including lymphomas. mi RNA profiling of the two NK /T cell lines vs. primary cells revealed 10 and 4 up‐regulated and 10 and 12 down‐regulated mi RNA s in SNK 6 and SNT 16 cells respectively. The results were validated by qRT ‐ PCR for selected mi RNA s. Target gene analyses confirmed cullin 5 ( CUL 5) and sphingosin‐1‐phosphate receptor 1 (S1 PR 1) as targets for the down‐regulated hsa‐miR‐148a and viral ebv‐miR‐ BART 16 respectively. As recently demonstrated for the regulation of IL 1‐alpha by miR‐142‐3p, coexpression of the EBER s selectively exerted corepression of S1 PR 1 by BART 16 but not of CUL 5 by miR‐148a, indicating selective corepression by the EBER s.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here